Publisher
Springer Berlin Heidelberg
Reference32 articles.
1. Guttermann JU, Mavligit GM, Gottlieb JA (1974) Chemoimmunotherapy of disseminated malignant melanoma with dimethyl triazano imidazole carboxamide (DTIC) and bacillus Calmette Guerin (BCG). N Engl J Med 291: 592–597
2. Chiba M, Jimboco K, Kizukuri K, Homma K (1982) Chemoimmunotherapy for disseminated malignant melanoma with DTIC, ACNU, VCR and OK 432.J Dermatol 9: 23
3. Veronesi U, Adamus J, Aubert C, Bajetta E, Beretta G, Bonadonna G, Bufalino R, Cascinelli N, Cocconi G, Durand J, De Marsillac J, Ikonopisov RL, Kiss B, Lejeune F, MacKie R, Madej G, Mulder H, Mechl Z, Milton GW, Morabito A, Peter H, Priario J, Paul E, Rumke P, Sertoli R, Tomin R (1982) A randomized trial of adjuvant chemotherapy and immunotherapy in cutaneous melanoma. N Engl J Med 307 (15): 913–916
4. Spitler LE, Sagebiel R (1980) A randomized trial of levamisole versus placebo as adjuvant therapy in malignant melanoma. N Engl J Med 303 (20): 1143–1147
5. Lejeune F, Macher E, Kleeberg UR, Rumke P, Prade M, Thomas D, Suciu S for the EORTC Malignant Melanoma Cooperative Group (1988) A randomized study on DTIC, levamisole and placebo as adjuvant treatment of high risk stage I primary melanoma. Eur J Cancer Clin Oncol 24: S81-S90